JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Published Online First: 10 September 2007. doi:10.1136/jnnp.2007.122028
Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:500-503
Copyright © 2008 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnnp.2007.122028v1
79/5/500    most recent
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wedderburn, C
Right arrow Articles by Williams-Gray, C
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedderburn, C
Right arrow Articles by Williams-Gray, C

RESEARCH PAPERS

The utility of the Cambridge Behavioural Inventory in neurodegenerative disease

C Wedderburn1, H Wear1, J Brown1, S J Mason1, R A Barker1,2, J Hodges2,3, C Williams-Gray1,2

1 Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
2 Department of Clinical Neuroscience, Addenbrooke’s Hospital, Cambridge, UK
3 MRC-Cognition and Brain Sciences Unit, 15 Chaucer Road, Cambridge, UK

Correspondence to:
Professor John Hodges, Prince of Wales Medical Research Institute, University of New South Wales, Barker St, Randwick, Sydney 2031, Australia; j.hodges{at}powmri.edu.au

We investigated the utility of the Cambridge Behavioural Inventory (CBI), a carer-completed questionnaire, in a large cohort with Parkinson’s disease (PD) (n = 215). In a sub-cohort of 112 patients with PD, the CBI was found to be a valid instrument compared with the Neuropsychiatric Inventory, PDQ-39 and UPDRS, with high internal consistency. Furthermore, in the whole cohort, the CBI was sensitive to changes in behaviour with disease progression. Comparison between CBI scores in PD and other neurodegenerative diseases, including Huntington’s disease (HD) (n = 75), Alzheimer’s disease (AD) (n = 96) and frontal variant frontotemporal dementia (fvFTD) (n = 64), revealed distinct profiles for each disease. Predominant deficits were "sleep"’ and "self care" in PD; "memory" in HD and AD; and "motivation" and "stereotypic behaviours" in fvFTD. The CBI is a robust, easy-to-use and valid instrument, which has the capacity to discriminate between neurodegenerative diseases, and may be of value in monitoring therapeutic interventions.




eLetters:

Read all eLetters

The utility of the Cambridge Behavioural Inventory in neurodegenerative disease
Andrew J Larner, et al.
JNNP Online, 29 May 2008 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.